158 related articles for article (PubMed ID: 8071051)
1. Double-blind study of a new nonionic contrast agent for digital subtraction arteriography.
Weiss JP; McLean GK; Modic MT; Rees CR; Higashida RT
Invest Radiol; 1994 May; 29 Suppl 1():S84-92. PubMed ID: 8071051
[TBL] [Abstract][Full Text] [Related]
2. A comparison of iopromide with iopamidol and iohexol for contrast-enhanced computed tomography.
Goldberg SN; Abrahams J; Drayer BP; Golding S; Bernardino M; Brunetti J
Invest Radiol; 1994 May; 29 Suppl 1():S76-83; discussion S93. PubMed ID: 8071050
[TBL] [Abstract][Full Text] [Related]
3. A double-blind study of iopromide 300 for peripheral arteriography. Results of a multi-institutional comparison of iopromide with iohexol and iopamidol.
Druy EM; Bettmann MA; Jeans W
Invest Radiol; 1994 May; 29 Suppl 1():S102-5; discussion S106. PubMed ID: 8071036
[TBL] [Abstract][Full Text] [Related]
4. Comparison of iopromide with iohexol and iopamidol in coronary arteriography and left ventriculography.
Bergelson B; Bettmann MA; Wexler L; Wilson R; Dyet J
Invest Radiol; 1994 May; 29 Suppl 1():S107-11; discussion S118-9. PubMed ID: 8071037
[TBL] [Abstract][Full Text] [Related]
5. Double-blind study of the safety, tolerance, and diagnostic efficacy of iopromide as compared with iopamidol and iohexol in patients requiring aortography and visceral angiography.
Faykus MH; Cope C; Athanasoulis C; Druy EM; Hedgcock M; Miller FJ; Bron K
Invest Radiol; 1994 May; 29 Suppl 1():S98-101; discussion S106. PubMed ID: 8071053
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of iopromide in cerebral arteriography.
Haughton VM; Papke RA; Hyland D; Drayer BP; Osborn AG; Maravilla K; Hilal SK
Invest Radiol; 1994 May; 29 Suppl 1():S94-7. PubMed ID: 8071052
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of iopromide for excretory urography.
Newhouse JH; Landman J; Lang E; Amis ES; Goldman S; Khazan R; Leder R; Hedgcock M
Invest Radiol; 1994 May; 29 Suppl 1():S68-73. PubMed ID: 8071049
[TBL] [Abstract][Full Text] [Related]
8. Analysis of renal and hepatic impairment by ionic and nonionic contrast media.
Langer M; Langer R; Felix R; Speck U; Behrends B; Mützel W
Invest Radiol; 1990 Sep; 25 Suppl 1():S125-6. PubMed ID: 2283230
[No Abstract] [Full Text] [Related]
9. Clinical experience with ioversol for angiography.
Bettmann MA
Invest Radiol; 1989 Jun; 24 Suppl 1():S61-6. PubMed ID: 2687199
[TBL] [Abstract][Full Text] [Related]
10. Peripheral arteriography with a new nonionic agent: comparison of iomeprol with iopamidol.
Ugolotti U; Larini P; Marcato C; Cusmano F; Puccianti F
Eur J Radiol; 1994 May; 18 Suppl 1():S77-82. PubMed ID: 8020523
[TBL] [Abstract][Full Text] [Related]
11. Pharmacochemical profile of iopromide.
Muetzel W; Speck U
AJNR Am J Neuroradiol; 1983; 4(3):350-2. PubMed ID: 6410742
[TBL] [Abstract][Full Text] [Related]
12. [Tolerability of nonionic contrast media--results of a multicenter double blind study].
Schmiedel E
Aktuelle Radiol; 1992 May; 2(3):148-52. PubMed ID: 1610929
[TBL] [Abstract][Full Text] [Related]
13. [Undesirable side effects of contrast media during i.v. DSA--a comparison of 2 nonionic contrast media].
Gross-Fengels W; Neufang KF; Siebert C; Lanfermann H; Steinbrich W
Rontgenblatter; 1990 Apr; 43(4):144-9. PubMed ID: 2187230
[TBL] [Abstract][Full Text] [Related]
14. Initial experience with a nonionic, dimeric contrast medium (iotrolan) in direct and indirect arteriography: a randomized, intraindividual double-blind study in 60 patients.
Hagen B; Wenzel-Hora BI
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():54-60. PubMed ID: 2568808
[TBL] [Abstract][Full Text] [Related]
15. Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide.
Pugh ND; Sissons GR; Ruttley MS; Berg KJ; Nossen JO; Eide H
Clin Radiol; 1993 Feb; 47(2):96-9. PubMed ID: 8435972
[TBL] [Abstract][Full Text] [Related]
16. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
Schmid I; Didier D; Pfammatter T; Garachemani A; Fleisch M; Kirchin MA; Meier B
Int J Cardiol; 2007 Jun; 118(3):389-96. PubMed ID: 17376548
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with iobitridol 250-300 in digital subtraction angiography. Double-blind randomized studies vs. iopromide and iohexol.
Bouard JC; Lyonnet D; Illes JP; Bouard-Monnier C; Rouviere O; Pangaud C
Acta Radiol Suppl; 1996; 400():85-8. PubMed ID: 8619361
[TBL] [Abstract][Full Text] [Related]
18. A double-blind study comparing the safety, tolerability, and efficacy of ioversol 320 and iopamidol-300 in cerebral angiography.
Ringel K; Kuehn J
Invest Radiol; 1989 Jun; 24 Suppl 1():S48-51. PubMed ID: 2687196
[TBL] [Abstract][Full Text] [Related]
19. Injection-associated pain in femoral arteriography: a European multicenter study comparing safety, tolerability, and efficacy of iodixanol and iopromide.
Justesen P; Downes M; Grynne BH; Lang H; Rasch W; Seim E
Cardiovasc Intervent Radiol; 1997; 20(4):251-6. PubMed ID: 9211770
[TBL] [Abstract][Full Text] [Related]
20. Iomeprol: current and future profile of a radiocontrast agent.
Katayama H; Spinazzi A; Fouillet X; Kirchin MA; Taroni P; Davies A
Invest Radiol; 2001 Feb; 36(2):87-96. PubMed ID: 11224756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
